The relationship between vitamin C and prolonging the life of cancer patients

Patients Feel Better With Treatment, Fewer Side Effects

A recent study found that adding high-dose intravenous vitamin C to the chemotherapy regimen doubled the survival rates of patients with metastatic pancreatic cancer at a late stage from 8 months to 16 months.

This disease is deadly, and the median survival is 8 months with treatment, and perhaps less without treatment, and the 5-year survival rate is considered poor.

The benefits of vitamin C for cancer patients

When the research team from the University of Iowa began the experiment, the researchers thought it would be successful if patients reached 12 months of survival.

However, according to "Study Finds", the results showed that the overall survival rate doubled to 16 months.

The experiment involved 34 patients with stage IV pancreatic cancer, and they were divided into two groups, the first of which received standard chemotherapy, and the second of which received the same treatment plus intravenous injections of 75 grams of vitamin C 3 times a week.

Improved treatment pattern

“Not only does the treatment increase overall survival, but patients seem to feel better with the treatment. They have fewer side effects, and they seem to be able to tolerate more of the treatment,” said Dr. Joseph Cullen, the researcher who led the study.